Ledger.Open graph →
SEC Form D · Amendment · filed March 30, 2016

SIAMAB THERAPEUTICS, INC

Offering
$7.0M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Brad Curley · Newton, MADirectorGary Pforzheimer · Newton, MADirectorJeffrey Behrens · Newton, MAExec · DirectorC. K. Garland · Houston, TXDirectorShirley K. Jeffries · Houston, TXDirectorScott K. Maclaren · Houston, TXExec · DirectorRobert Mashal · Aurora, CODirectorPeter Kroon · Newton, MADirectorJames D. Carey · New York, NYExec · DirectorThomas W. Corbett · NEWPORT BEACH, CADirectorTed C. Filley · NEWPORT BEACH, CADirectorRobert Mashal · Newton, MADirectorPeter Kroon · Newton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗